Innovative soft tissue repair implant undergoes successful first-in-man trial

nanoMesh LLC, a subsidiary of Exogenesis Corporation, announced yesterday that it successfully initiated First-In-Man implantation of its proprietary soft tissue repair device, Exogenesis nanoMesh. 

Exogenesis expects additional implantations during Q2, concurrent with national distribution.

The patient, a 74 year old male presented with a ventral hernia becoming progressively more symptomatic. The hernia sac was large and distorting normal abdominal wall contour, despite central obesity. He underwent a ventral hernia repair utilizing an Exogenesis nanoMesh placed in the retrorectus position, and the defect was closed. There were no complications.

Exogenesis Hernia Mesh (nanoMesh) is an innovative soft tissue repair implant, constructed of monofilament polypropylene (PP) and possesses a unique nanometer-level surface texture, via the application of Accelerated Neutral Atom Beam (ANAB) technology during manufacturing.

The implant is indicated for the repair of abdominal wall hernias and abdominal wall deficiencies that require the addition of reinforcing material to obtain the desired surgical result. Exogenesis nanoMesh is expected to be commercially available throughout the US during 2021.